ROBERT F APPLE
CIK 1054942 · President and CEO · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.24M
Companies
3
Total Filings
60
Lifetime Open-Market Net
-$5.72M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-05 | ANTARES PHARMA, INC. (ATRS) Delisted | Tax (F) | −34,402 | -$92.5K | EDGAR |
| 2018-05-30 | ANTARES PHARMA, INC. (ATRS) Delisted | Tax (F) | −13,480 | -$32.8K | EDGAR |
| 2018-05-14 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +52,448 | -$5.6K | EDGAR |
| 2018-02-26 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +76,834 | -$81.4K | EDGAR |
| 2017-06-12 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | +338,115 | $899.4K | EDGAR |
| 2017-06-09 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | −390,593 | -$1.05M | EDGAR |
| 2017-04-05 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | — | -$54.1K | EDGAR |
| 2016-12-29 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +20,283 | -$19.5K | EDGAR |
| 2016-06-30 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | +11,223 | $11.8K | EDGAR |
| 2016-06-06 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | +363,150 | $406.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.